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MEDICARE AND MEDICAID ENROLLMENT AND 
UTILIZATION AMONG HIV-INFECTED AND UNINFECTED 
VETERANS IN VA CARE Harry Chang, Michael E. Ohl, Janet Tate, 
Amy C. Justice. Section of General Internal Medicine, Department of Internal 
Medicine, Yale University, School of Medicine, New Haven, CT. 
 
ABSTRACT: Many veterans engaged in care with the Veterans Administration (VA) 
health system are also enrolled in Medicare and/or Medicaid and may receive care both 
inside and outside of the VA. Use of dual health systems has been associated with worse 
outcomes. Veterans with human immunodeficiency virus (HIV) may have different rates 
of Medicare and Medicaid enrollment, and may be at greater risk of poor outcomes 
related to non-VA use. This study compares the frequency of Medicare and/or Medicaid 
enrollment and factors associated non-VA use in an HIV-infected and uninfected 
population of veterans. 
 
We used data from the VA and Center for Medicare & Medicaid Services from 2004 and 
2005 to determine the frequency of Medicare and/or Medicaid enrollment among a cohort 
of HIV-infected and uninfected veterans engaged in VA care.  We then restricted the 
study population to veterans enrolled in fee-for-service (FFS) Medicare and/or Medicaid 
with at least one hospitalization, and identified characteristics associated with non-VA 
hospital admissions. 
 
 
 
2 
 
HIV-infected veterans had higher rates of Medicare and/or Medicaid enrollment than 
uninfected veterans (38% vs. 33%, p<0.01), though the opposite was true when our 
sample was limited to veterans 65 years and older (53% vs. 70%, p<0.0 1). Among 
veterans enrolled in the VA and FFS Medicare and/or Medicaid, veterans with HIV had 
greater illness severity and more frequent hospitalizations, but were less likely to be 
hospitalized outside the VA (48% vs. 54%, p<0.01). HIV infection was associated with 
lower odds of outside hospitalization (OR=0.76 [95% CI: 0.68, 0.85]). 
 
Veterans with HIV have higher rates of Medicare and/or Medicaid enrollment, but lower 
odds of non-VA hospitalization.  The VA integrated model of HIV care may encourage 
“inside” health care use among HIV-infected veterans.  
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Introduction 
Overview of 1995 Reform 
In the mid-1990s, the Veterans Health Administration (VHA) responded to decreased 
demand and a reputation for disorganization and poor quality with a comprehensive 
reform of its care delivery system. It reorganized its hundreds of medical centers and 
clinics into 23 regional, vertically integrated care networks (Veteran’s Integrated Service 
Network or VISNs), adopted new technologies including electronic medical records 
(EMR), implemented capitation funding, and placed new emphasis on primary care. 
These moves, which presaged changes seen in the larger U.S. healthcare system today, 
were aimed at improving care coordination, quality and patient experience. 
 
At the VA, improvement in care coordination was driven by primary care. Historically, 
the VA had focused more on hospital based medicine and specialty care that veterans had 
difficulty finding in the community. However, recognizing that that their patient 
population was aging and the increasing prevalence of chronic diseases, the VA changed 
its physician mix through increased hiring of primary care providers (PCP) and support 
staff. In 1995, prior to the reforms, only about 10% of veterans were assigned a primary 
care provider. Four years later, essentially all patients were assigned a PCP and a primary 
care team, and more than 80% of veterans could name their PCP [1]. These primary care 
teams were accountable for the health of their patients and were aided by systems put in 
place to support sharing of information. These included increase physician notifications 
and involvement of primary care teams in hospital admissions, ER, urgent care and 
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specialist visits, case management, and a shared EMR. EMR technology was also 
leveraged to develop performance measures and quality improvement programs. 
 
An evaluation of quality of care at VA after the implementation of these reforms found 
year-to-year improvement in metrics assessing preventive medicine, as well as outpatient 
and inpatient care. It also found that the VA outperformed fee-for-service Medicare in 
nearly all of these metrics [2]. 
Background 
Although VA reforms have led to demonstrable success in care coordination and quality, 
its progress is affected by high rates of enrollment in outside insurance programs. 
Previous work has described Medicare and/or Medicaid (“CMS enrollment”) and 
identified factors that influence non-VA use (“CMS use”) among veterans eligible for 
VA care, particularly those 65 years and older that have age qualified for Medicare [3-6]. 
These studies have shown rates of Medicare enrollment among veterans 65 years and 
older exceeding than 90% [3], and identified factors such as distance to the VA, priority 
status, and health status contribute to decisions to seek non-VA care [4]. 
 
Less well characterized is the frequency of CMS enrollment among veterans actively 
utilizing VA care, and the factors that contribute to their decision to utilize dual health 
systems, including veterans under age 65 and those enrolled in Medicaid. An expansion 
of Medicaid coverage under the Patient Protection and Affordable Care Act of 2010 
(ACA) will likely lead to an increase in the proportion of CMS enrolled veterans [7]. Use 
of non-VA health care among veterans already engaged in VA care has been shown to 
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lead to waste [8], as well as fragmented, lower quality care, and increased mortality [9-
12]. 
 
Use of dual health systems is particularly worrisome for patients with complicated 
chronic conditions like HIV. As HIV-infected veterans age they are vulnerable to adverse 
outcomes because of the complexity of their care needs, including multimorbidity, 
polypharmacy, mental health issues, and substance use [13-15]. Moreover, people living 
with HIV are more likely to qualify for Medicare through disability than age, and 
Medicare currently provides coverage for approximately one-fifth of the people receiving 
HIV care in the U.S. [16]. Medicaid coverage for HIV varies on a state-to-state basis, but 
it currently covers about 50% of the people receiving HIV care in the U.S. [17]. 
 
The VA is the largest provider of care for persons with HIV in the United States, with 
over 20,000 veterans in care, and significant resources have been invested to create an 
integrated HIV care model [18, 19]. The integrated model for HIV care in VA includes 
on-site pharmacy services and emphasizes case management; and it also provides access 
to coordinated medical and behavioral health care services, including mental health care, 
urgent care, and substance abuse treatment.  Previous research has demonstrated the 
success of the integrated care model at the VA – showing higher rates of viral load 
suppression in clinics with greater integration of care [15]. Given the high, and 
potentially expanding, rates of CMS enrollment in the HIV population, an understanding 
of Medicare and Medicaid enrollment and the frequency and drivers of CMS use among 
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HIV-infected veterans accessing VA care is necessary to inform efforts to coordinate 
care. 
Statement of Purpose 
The objectives of this paper were to: 1) determine the frequency of Medicare and/or 
Medicaid enrollment among HIV-infected, compared with uninfected veterans, veterans 
engaged in VA care; 2) determine the frequency of non-VA hospital admissions among 
male, CMS enrolled HIV-infected and uninfected veterans with any hospitalizations; and 
3) identify characteristics that predict non-VA hospital admission among male HIV-
infected veterans, compared with uninfected veterans, enrolled in Medicare and/or 
Medicaid.   We hypothesized that the integrated system of care HIV-infected veterans 
receive at the VA would lead to less non-VA use among CMS enrolled HIV-infected 
veterans than their uninfected counterparts. 
Methods 
This retrospective cohort study included two source populations of veterans in VA care in 
the United States during 2004 and 2005: 1) HIV-infected veterans; and 2) age, race and 
facility-matched uninfected comparators. 
 
We used data from the Veterans Aging Cohort Study (VACS), a multi-site, prospective, 
observational cohort study of HIV infected veterans and age, race and site-matched 
controls. VACS was started in 1999 and was designed to evaluate the impact of 
comorbidities and behavior on HIV outcomes. Since then it has expanded to nine urban 
sites throughout the U.S., where it enrolls patients seen in infectious disease and general 
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medicine clinics. VACS also includes a virtual cohort (VACS-VC), a nationally 
representative sample of HIV-infected veterans and matched uninfected controls 
identified through the VA electronic medical record (EMR) system and followed since 
1996 [17, 18]. For this analysis, we derived our sample from the VACS-VC. 
 
Demographic data, medical diagnoses (based on International Classification of Diseases, 
Ninth Revision, Clinical Modification [ICD-9-CM] codes), and laboratory results were 
extracted from VA EMR.  Medicare and/or Medicaid enrollment and utilization for these 
veterans were extracted from data provided by the Center for Medicare & Medicaid 
Services (CMS). The study received approval from the Human Investigations Committee 
at Yale University and the Human Studies Subcommittee of the VA Connecticut 
Healthcare System and was granted a waiver of informed consent. 
 
We started with a source population that included all veterans enrolled in the VACS-VC 
prior to January 1, 2003 (cohort 1 in Figure 1) and engaged in VA care. For the purpose 
of this analysis, we defined engaged in care as at least one inpatient or outpatient visit to 
a VA medical center in 2003. Using CMS enrollment data, we determined the frequency 
of Medicare and/or Medicaid enrollment in this cohort. To study frequency and drivers of 
CMS use, we limited our cohort of VA enrolled veterans to include only those with 
coverage for CMS use. We narrowed our sample to veterans that were CMS enrolled in 
the 2004 and 2005 calendar years, and had at least one inpatient admission in either VA 
or non-VA hospitals during this same period. From this group, we excluded those CMS 
enrolled for less than 18 months in the 24-month period, enrolled in HMO plans (as 
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defined in the CMS data file), and enrolled in Medicaid in more than one state. Finally, 
we excluded female veterans, due to their low numbers in our final sample (cohort 2 in  
FIGURE 1: Cohort development for 2004 dual enrollment and dual use in 2004-
2005
 
1
 Veterans Aging Cohort Study Virtual Cohort 
2
 Veterans Administration 
3
 4827 veterans excluded because died in 2004 or 2005 
4
 Health Maintenance Organization 
5
 Fee-for-service  
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Figure 1).  Our final sample consisted of 7,765 male HIV infected and uninfected 
veterans enrolled in FFS Medicare and/or Medicaid, with at least one inpatient admission 
in 2004 and 2005. We used this cohort to determine the frequency and predictors of non-
VA hospital admissions. 
 
We created a series of variables to identify factors associated with non-VA hospital 
admissions among male veterans, who were enrolled in fee for service (FFS) Medicare 
and/or Medicaid, and who received inpatient care in 2004 and 2005 (cohort 2).  Our 
dependent variable was a dichotomous indicator of any non-VA admissions, (vs. only VA 
inpatient admissions). Hospital admissions were identified by combining VA EMR data 
with CMS FFS reimbursement files. 
 
We considered a number of independent variables that could possibly influence use of 
non-VA inpatient care, including demographic factors, access to care, illness severity, 
and admission to a medical or surgical intensive care unit (ICU). Age and race data were 
taken from VA administrative databases. Age was constructed as a dichotomous variable: 
under age 65 and 65 years and older. Race was divided into three categorical variables: 
White, African American, and Other. 
 
Patients’ access to care was measured by three variables: a) enrollment in Medicare, 
Medicaid, or both programs; b) distance to nearest VA tertiary care center treated as a 
categorical variable: 0 to 9.9 miles, 10-29.9 miles, 30-59.9 miles, 60-119.9 miles, and 
greater than 120 miles [19]; and an indicator of whether veterans were subject to co-pays 
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for VA care.  Co-pay status was in turn determined using data on service connection, 
medical conditions, and an income-based “means test” for each veteran.   
 
We used the CMS hierarchical condition categories (HCC) model to calculate risk scores 
[20], and used the scores as a measure of patients’ illness severity. The HCC model is a 
risk adjustment method employed by CMS to predict prospective payments for patients 
based on the previous year’s claims data, using patient demographics and major medical 
conditions; it has been applied to the VA population in the past for similar analyses [7]. 
Each year the average risk score is set at one, and we divided our HCC risk scores into a 
dichotomous variable: scores greater than one and scores less than or equal to one. We 
created a binary variable for HIV status, identified through VA administrative data. We 
also used VA administrative data to identify veterans that carried a diagnosis of a 
substance use problem (illicit substance abuse or dependence), using ICD-9CM codes 
and a previously validated algorithm available on the VACS website (vacohort.org). 
 
We generated categorical variables for number of inpatient admissions (one vs. two or 
more) and the admission diagnosis (ICU vs. non-ICU admission), because we believe 
both could influence the likelihood of a veteran having a non-VA admission. Veterans 
with more frequent admissions have more “opportunities” to be hospitalized in a non-VA 
facility. Similarly, patients in critical condition, requiring admission to ICUs, may be 
more likely to be routed to a non-VA hospital. Though these variables do not reflect 
patient behavior, they may influence the likelihood of an admission outside the VA and, 
thus, we controlled for these factors in our model. 
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Analysis 
We first examined veterans in the VACS-VC (cohort 1) to determine the frequency of 
CMS enrollment among veterans engaged in care. We stratified our analysis by age and 
HIV status, and used student t-tests to compare the frequency of CMS enrollment 
between HIV-infected and uninfected veterans. Next, we described the cohort of male, 
veterans enrolled in FFS Medicare and/or Medicaid with at least one inpatient admission 
(cohort 2) using the independent variables listed above. We stratified cohort 2 by HIV 
status, and used chi-square tests to compare the two sub-populations. Finally, we 
explored the unadjusted and adjusted association between these independent variables 
and non-VA hospital admissions using logistic regression. We created a multivariate 
model that included all patients in cohort 2, as well as separate models stratified by HIV 
status. All analyses were conducted using SAS version 9.2. 
Results 
Overall, HIV-infected veterans engaged in VA care were more likely than uninfected 
veterans to be enrolled in Medicare and/or Medicaid (38% vs. 33%, p<0.01) (Table 1). 
Whereas HIV-infected veterans under age 65 were more likely to be CMS enrolled than 
uninfected veterans, (36% vs. 29%, p<0.01), HIV-infected veterans 65 years and older 
were less likely to be CMS enrolled (53% vs. 70%, p<0.01). The majority of CMS 
enrolled veterans were enrolled in Medicare, but HIV-infected veterans were more likely 
than uninfected veterans to be enrolled in Medicaid, either alone or in combination with 
Medicare. 
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TABLE 1: Medicare and/or Medicaid enrollment among veterans enrolled in VACS-
VC1 in 2004 
 
 
1
 Veterans Aging Cohort Study – Virtual Cohort 
2
Center for Medicare & Medicaid Service 
 
Among veterans enrolled in FFS Medicare and/or Medicaid with at least one inpatient 
admission (cohort 2), the frequency of non-VA hospitalizations among HIV-infected 
veterans was lower than the frequency among uninfected veterans (48% vs.54%, p<0.01) 
(Table 2). Compared to uninfected veterans, HIV-infected veterans were younger and 
lived closer to VA hospitals. A greater proportion of HIV-infected veterans also reported 
African American race, had an HCC score greater than 1, and carried a diagnosis of 
substance use problem. 
 
  
 
ALL 
PATIENTS 
n (%) 
HIV+ 
n (%) 
HIV- 
n (%) p-value 
Total Unique in VACS-VC n=91369 n=29909 n=61460 
 Medicare Only 20964 (23) 6461 (22) 14503 (24) <.0001 
Medicaid Only 5220 (6) 2203 (7) 3017 (5) <.0001 
Medicare and Medicaid 5290 (6) 2618 (9) 2672 (4) <.0001 
Total Enrolled in CMS
2
 31474 (34) 11282 (38) 20192 (33) <.0001 
     
Under 65 n=82835 n=27193 n=55642 
 Medicare Only 16309 (20) 5334 (20) 10975 (20) 0.7111 
Medicaid Only 5187 (6) 2190 (8) 2997 (5) <.0001 
Medicare and Medicaid 4475 (5) 2329 (9) 2146 (4) <.0001 
Total Enrolled in CMS 25971 (31) 9853 (36) 16118 (29) <.0001 
     65 and over n=8534 n=2716 n=5818 
 Medicare Only 4655 (55) 1127 (41) 3528 (61) <.0001 
Medicaid Only 33 (0) 13 (0) 20 (0) 0.3497 
Medicare and Medicaid 815 (10) 289 (11) 526 (9) 0.0192 
Total Enrolled in CMS 5503 (64) 1429 (53) 4074 (70) <.0001 
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TABLE 2: CMS1 enrolled veterans with 1 or more inpatient admissions in 2004 and 
2005 
 
 
ALL PATIENTS n (%) HIV+ n (%) HIV- n (%) p-value 
 
 
n=7765 n=2799 n=4966 
 DEMOGRAPHICS 
     Age 
     <65 6319 (81) 2405 (86) 3914 (79) <.0001 
 ≥65 1446 (19) 394 (14) 1052 (21) 
  Race 
     White 3903 (50) 1343 (48) 2560 (52) 0.009 
 African American 3755 (48) 1413 (50) 2342 (47) 
  Other 107 (2) 43 (2) 64 (1) 
  Distance from VA 
     0-9.9 miles 3253 (42) 1445 (52) 1808 (36) <.0001 
 10-29.9 miles 1824 (24) 599 (21) 1225 (25) 
  30-59.9 miles 1270 (16) 393 (14) 877 (18) 
  60-119.9 miles 1192 (15) 310 (11) 882 (18) 
  ≥120 miles 224 (3) 52 (2) 172 (3) 
  Co-pay status 
     No Co-pay 7174 (95) 2592 (96) 4582 (95) 0.0997 
 Co-pay 352 (5) 112 (4) 240 (5) 
 ENROLLMENT 
     Medicare Only 6408 (83) 2088 (74) 4320 (87) <.0001 
 Medicaid Only 469 (6) 274 (10) 195 (4) 
  Medicare and Medicaid 888 (11) 437 (16) 451 (9) 
 HEALTH 
     HIV 
     Positive 2799 (36) 
    Negative 4966 (64) 
    HCC Risk Score
2
 
     <1 4129 (53) 1040 (37) 3089 (62) <.0001 
 ≥1 3636 (47) 1759 (63) 1877 (38) 
 INPATIENT ADMISSIONS 
    Number of Admissions 
     1 3186 (41) 1091 (39) 2095 (42) 0.0058 
 ≥2 4579 (59) 1708 (61) 2871 (58) 
  ICU
3
 Admission 
     Yes 1637 (21) 575 (21) 1062 (21) 0.3822 
 No 6128 (79) 2224 (79) 3904 (79) 
  Substance Abuse 
     Yes 1958 (25) 828 (30) 1130 (23) <.0001 
 No 5807 (75) 1971 (70) 3836 (77) 
  UTILIZATION 
     VA
4
 Admissions Only 3757 (48) 1467 (52) 2290 (46) <.0001 
 Non-VA Admission 4008 (52) 1332 (48) 2676 (54) 
 
 
1
 Center for Medicare & Medicaid Serivces 
2
 Hierarchical Conditional Category Risk Score 
3
 Intensive Care Unit 
4
 Veterans Administration  
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In unadjusted analysis, HIV-infected veterans had lower odds of non-VA hospitalizations 
than uninfected veterans (OR=0.78 [95% CI: 0.71, 0.85]) (Table 3). In addition, older 
veterans and veterans with higher HCC risk scores had greater odds of CMS use than 
their respective younger and healthier counterparts. Among HIV-infected veterans, a 
substance abuse diagnosis was associated with increased non-VA use (OR=1.34 [95% 
CI: 1.14, 1.58]); a significant association was not found between substance abuse and 
non-VA use in uninfected veterans (OR=0.91 [95% CI: 0.80, 1.04]).  
 
The association between HIV status and decreased odds of non-VA admissions remained 
in the multivariable model (OR=0.76 [95% CI: 0.68, 0.85]), whereas the association 
between higher HCC risk score and increased non-VA use was not significant (Table 4). 
We posited that number of admissions, which had the greatest marginal effect (OR=3.10 
[95% CI: 2.79, 3.45])on the multivariate model, was masking the effects of other 
variables. When we removed number of admissions from the adjusted model (analysis 
not shown), both higher HCC risk score and African American race had significant 
associations with increased non-VA use (OR=1.28 [95% CI: 1.13, 1.44] and OR= 1.18 
[95% CI: 1.05, 1.33], respectively). 
 
When stratifying by HIV statuses, the predictors of CMS use were similar in both the 
HIV-infected and uninfected models (Table 4). 
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TABLE 3: Characteristics associated with non-VA inpatient admissions in 2004 and 2005, 
bivariate analysis 
  
ALL PATIENTS p-value HIV+ p-value HIV- p-value 
DEMOGRAPHICS 
      
 
Age 
      
 
<65 Ref 
 
Ref 
 
Ref 
 
 
≥65 1.86 (1.65-2.09) <.0001 1.39 (1.12-1.72) 0.0028 2.05 (1.77-2.36) <.0001 
 
Race 
      
 
White Ref 
 
Ref 
 
Ref 
 
 
African American 0.96 (0.87-1.04) 0.3126 1.08 (0.93-1.26) 0.3031 0.90 (0.81-1.01) 0.0696 
 
Other 3.40 (2.13-5.41) <.0001 3.39 (1.70-6.79) 0.0006 3.58 (1.90-6.74) <.0001 
 
Distance from VA 
      
 
0-9.9 miles Ref 
 
Ref 
 
Ref 
 
 
10-29.9 miles 1.30 (1.16-1.46) <.0001 1.16 (0.96-1.40) 0.1297 1.37 (1.19-1.59) <.0001 
 
30-59.9 miles 1.75 (1.54-2.00) <.0001 1.45 (1.16-1.81) 0.0012 1.91 (1.62-2.25) <.0001 
 
60-119.9 miles 2.55 (2.22-2.93) <.0001 1.92 (1.49-2.46) <.0001 2.82 (2.38-3.34) <.0001 
 
≥120 miles 2.41 (1.82-3.20) <.0001 2.95 (1.62-5.37) 0.0004 2.26 (1.63-3.12) <.0001 
 
Co-pay status 
      
 
No Co-pay Ref 
 
Ref 
 
Ref 
 
 
Co-pay 2.58 (2.04-3.27) <.0001 1.92 (1.30-2.84) 0.001 3.01 (2.22-4.08) <.0001 
ENROLLMENT 
      
 
Medicare Ref 
 
Ref 
 
Ref 
 
 
Medicaid 1.94 (1.60-2.36) <.0001 2.51 (1.94-3.27) <.0001 1.75 (1.30-2.36) 0.0003 
 
Medicare and Medicaid 2.40 (2.07-2.79) <.0001 2.95 (2.38-3.68) <.0001 2.26 (1.83-2.80) <.0001 
HEALTH 
      
 
HIV 
      
 
Positive 0.78 (0.71-0.85) <.0001 
    
 
Negative Ref 
     
 
HCC Risk Score
1
 
      
 
<1 Ref 
 
Ref 
 
Ref 
 
 
≥1 1.14 (1.04-1.25) 0.004 1.26 (1.08-1.46) 0.0039 1.21 (1.08-1.36) 0.0014 
INPATIENT ADMISSIONS 
     
 
Number of Admissions 
      
 
1 Ref 
 
Ref 
 
Ref 
 
 
≥2 3.06 (2.79-3.37) <.0001 4.29 (3.64-5.06) <.0001 2.64 (2.35-2.97) <.0001 
 
ICU
2
 Admission 
      
 
Yes 2.21 (1.97-2.47) <.0001 2.00 (1.66-2.42) <.0001 2.34 (2.02-2.70) <.0001 
 
No Ref 
 
Ref 
 
Ref 
 
 
Substance Abuse 
      
 
Yes 1.04 (0.94-1.15) 0.4531 1.34 (1.14-1.58) 0.0004 0.91 (0.80-1.04) 0.1549 
 
No Ref 
 
Ref 
 
Ref 
 
 
1
 Hierarchical Conditional Category Risk Score 
2
 Intensive Care Unit 
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TABLE 4: Characteristics associated with non-VA inpatient admissions in 2004 and 2005, 
multivariate analysis 
  
ALL PATIENTS p-value HIV+ p-value HIV- p-value 
DEMOGRAPHICS 
      
 
Age 
      
 
<65 Ref 
 
Ref 
 
Ref 
 
 
≥65 1.90 (1.65-2.17) <.0001 1.61 (1.25-2.08) 0.0002 2.00 (1.70-2.35) <.0001 
 
Race 
      
 
White Ref 
 
Ref 
 
Ref 
 
 
African American 1.05 (0.94-1.16) 0.4032 1.02 (0.86-1.22) 0.8293 1.07 (0.94-1.22) 0.3128 
 
Other 3.17 (1.91-5.27) <.0001 3.58 (1.63-7.85) 0.0015 2.98 (1.52-5.83) 0.0015 
 
Distance from VA 
      
 
0-9.9 miles Ref 
 
Ref 
 
Ref 
 
 
10-29.9 miles 1.51 (1.33-1.72) <.0001 1.41 (1.13-1.75) 0.0022 1.59 (1.35-1.86) <.0001 
 
30-59.9 miles 2.08 (1.79-2.41) <.0001 1.78 (1.38-2.30) <.0001 2.25 (1.87-2.70) <.0001 
 
60-119.9 miles 3.42 (2.92-4.01) <.0001 3.06 (2.29-4.09) <.0001 3.62 (2.99-4.37) <.0001 
 
≥120 miles 3.06 (2.23-4.19) <.0001 5.67 (2.90-11.06) <.0001 2.61 (1.83-3.74) <.0001 
 
Co-pay status 
      
 
No Co-pay Ref 
 
Ref 
 
Ref 
 
 
Co-pay 2.66 (2.05-3.46) <.0001 2.61 (1.68-4.05) <.0001 2.76 (1.99-3.84) <.0001 
ENROLLMENT 
      
 
Medicare Ref 
 
Ref 
 
Ref 
 
 
Medicaid 2.83 (2.28-3.52) <.0001 2.93 (2.17-3.94) <.0001 2.57 (1.85-3.57) <.0001 
 
Medicare and Medicaid 2.50 (2.11-2.95) <.0001 2.89 (2.27-3.69) <.0001 2.17 (1.72-2.73) <.0001 
HEALTH 
      
 
HIV 
      
 
Positive 0.76 (0.68-0.85) <.0001 
    
 
Negative Ref 
     
 
HCC Risk Score
1
 
      
 
<1 Ref 
 
Ref 
 
Ref 
 
 
≥1 0.99 (0.89-1.10) 0.8071 0.95 (0.79-1.14) 0.5937 1.01 (0.88-1.15) 0.9127 
INPATIENT ADMISSIONS 
     
 
Number of Admissions 
      
 
1 Ref 
 
Ref 
 
Ref 
 
 
≥2 3.10 (2.79-3.45) <.0001 4.45 (3.69-5.37) <.0001 2.62 (2.30-2.98) <.0001 
 
ICU
2
 Admission 
      
 
Yes 1.73 (1.52-1.96) <.0001 1.42 (1.15-1.76) 0.0012 1.94 (1.65-2.27) <.0001 
 
No Ref 
 
Ref 
 
Ref 
 
 
Substance Abuse 
      
 
Yes 1.16 (1.03-1.31) 0.0179 1.28 (1.05-1.55) 0.0138 1.08 (0.92-1.26) 0.3356 
 
No Ref 
 
Ref 
 
Ref 
 
 
1
 Hierarchical Conditional Category Risk Score 
2
 Intensive Care Unit 
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Discussion 
In our sample of veterans engaged in VA care, we found that HIV-infected veterans were 
more likely than their uninfected counterparts to be enrolled in Medicare and/or 
Medicaid, but this difference varied by age. HIV-infected veterans under age 65 were 
more likely to be CMS enrolled, whereas HIV-infected veterans 65 years and older were 
much less likely to be CMS enrolled. Confirming our a priori hypothesis, we also found 
that male, HIV-infected veterans enrolled in FFS Medicare and/or Medicaid were less 
likely to have a non-VA hospitalization. This pattern was evident despite the fact that 
these veterans were generally sicker, more likely to have multiple admissions, and more 
likely to be enrolled in FFS Medicaid – all independent risk factors for greater non-VA 
use. 
 
We suspect that HIV-infected veterans were less likely to use non-VA hospitals because 
they feel more tied to the VA – possibly due to the integrated care and various providers 
they see in VA infectious disease clinics, or the desire for continuity with established 
caregivers for what is historically a stigmatized disease. The prescription drug coverage 
afforded veterans – and the high costs of antiretroviral therapy – may also play a 
significant role. Although every state provides some coverage for antiretroviral drugs, the 
coverage varies substantially; very few states cover as many of these drugs as are covered 
nationally within VA. This explanation is also supported from patient self report data in 
VACS8 in which 96% of those on ART reported getting all their antiretroviral 
medications through VA [17]. 
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Our findings on frequency of CMS enrollment among veterans were not completely 
consistent with previous literature. Overall, we found lower rates of Medicare enrollment, 
but higher rates of enrollment in Medicaid [21]. This difference was particularly evident 
among veterans 65 years and older, for whom Medicare enrollment has been reported to 
be greater than 90% [7, 21]. Our results are likely driven primarily by our initial cohort 
(cohort 1), which included only patients who were already engaged in VA care, i.e. were 
seen at the VA at least once in the past year. We suspect that veterans already receiving 
care at the VA are less likely to seek alternative forms of coverage than all veterans ever 
enrolled in VA care. The difference may also be partially attributed to the greater share of 
HIV-infected veterans in our sample than in previously studied groups. VACS-VC is a 
nationally representative sample of HIV-infected veterans, not all veterans enrolled in 
VA care. As noted in the background section, HIV-infected veterans differentially qualify 
for Medicare coverage, primarily through disability [10]. Similarly, we believe that 
comorbid and socioeconomic factors that contribute to higher rates of Medicaid 
enrollment among all persons living with HIV contributed to the higher rates of Medicaid 
enrollment in our sample of veterans. Among HIV infected and uninfected veterans, 
some of these changes may also be partially driven by a change in the population 
utilizing VA care since 1999 [8, 21], when previous reports were published. Our results 
are based on data from from five years later, and may also reflect an evolving perception 
of VA care or increased Medicare cost sharing. 
 
Our findings regarding predictors of non-VA hospitalization among CMS enrolled 
veterans engaged in VA care were consistent with previous literature.  In general, these 
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studies have found older age, increased distance to the VA, greater cost-sharing and 
worse health to be associated with non-VA use [7,8, 22,23]. Our results confirm these 
findings among HIV-infected veterans, and serve as a reminder to VA care providers 
regarding patients that are more likely to receive non-VA care and thus benefit from care 
coordination efforts with outside providers. 
 
Our results should be viewed in light of several limitations – most importantly, our 
limited access to data on private insurance enrollment and utilization in the VA 
population. As a result of the lack of claims data for patients hospitalized under private 
insurance, some patients classified as having only VA admissions may actually have 
unaccounted for admissions to non-VA hospitals. Moreover, CMS enrollment with 
private insurance may lead to significantly lower costs for veterans, influencing their 
choice of health care setting. The VACS does collect some survey data on private 
insurance enrollment. Among veterans in VACS8, 15% of HIV-infected veterans and 
20% of uninfected veterans reported enrollment in private insurance (analysis not 
shown). Given the lower rates of supplemental insurance in the HIV-infected population, 
we believe our finding that HIV-infected veterans are less likely to have non-VA 
admissions likely still holds true. Another limitation is that inpatient admissions are 
commonly influenced by factors beyond patient preference. Although we controlled for 
those variables in our analysis, inpatient admissions as an outcome variable may limit the 
conclusions that can be drawn from our results. We chose inpatient admissions because 
non-VA inpatient care places HIV-infected veterans at risk for adverse events, related to 
poor coordination of care transitions between outside hospitals and VHA HIV clinics. We 
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recognize, however, that choice in outpatient setting may be a better reflection of patient 
preferences (and will be the subject of future studies). We also did not take into account 
pathways to CMS enrollment. Veterans that were enrolled in Medicare or Medicaid prior 
to engagement with the VA system may be more likely to have non-VA admissions; the 
opposite may be true of veterans that were seeking care with the VA prior to enrolling 
with Medicare and/or Medicaid. In addition, though most HIV infected people with 
Medicare qualify through disability, it is unknown if this association is also true among 
veterans.  
 
The heterogeneity of Medicare and/or Medicaid from state to state also limits our ability 
to generalize the data. Medicare Advantage plans, i.e. managed care plans provided by 
private insurers, are highly variable by design, and Medicaid benefits and eligibility vary 
from state to state. Moreover, to date only 26 of the 50 states have chosen to accept the 
ACA provision to expand Medicaid, making comparisons between states more difficult in 
the post-ACA era. Finally, our findings are limited by the age of our data. We restricted 
our analysis to 2004 and 2005, the latest years we had complete data available. 
Nonetheless, our analysis uses more recent data than similar studies analyzing CMS 
enrollment and CMS use.  
Conclusion 
Many veterans engaged in care in the VA are also enrolled in Medicare and/or Medicaid, 
including a significant proportion of veterans under age 65. Like the general population, 
the rates of CMS enrollment are higher among HIV infected veterans. Among veterans 
enrolled in both VA and CMS care, however, HIV-infected veterans have lower odds of 
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non-VA hospitalization – despite having greater illness severity and more frequent 
hospitalizations than uninfected veterans. The VA’s integrated model of care used to treat 
HIV/AIDS may explain why HIV-infected veterans were more likely to seek care within 
the VA. 
 
The impact of CMS use on veterans with HIV and other complex medical conditions 
requires further investigation. HIV-infected veterans have complicated medical histories 
and are likely to experience inefficient care and poor outcomes related to non-VA use. 
Research that provides evidence of the cost and health implications of CMS use may 
guide the VA in how aggressively to pursue and try to retain these patients in the VA 
system. 
 
Future research should also explore why veterans with HIV were less likely than 
uninfected veterans to use non-VA care.  If specific aspects of VA’s integrated care 
programs for veterans with HIV, such as intensive case management, are found to 
contribute to lower likelihood of non-VA admission, then this would inform strategies to 
limit non-VA use among other veteran populations at high risk from fragmented care, 
such as veterans with other major chronic diseases or illnesses. 
 
CMS enrollment is a valuable resource for veterans who face higher copayments or live 
long distances from VA medical centersyet among some veterans, CMS enrollment may 
lead to inefficient care and poor health outcomes. As health coverage is further expanded, 
efforts should be made to ensure that additional coverage is reaching the populations that 
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can benefit the most. The VA and federal government should shape their policies to 
incentivize use of a single health system, and also develop procedures to ensure 
comprehensive exchange of information between health systems. 
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